I also remember when I was at the meeting that the strategy management is taking and outlined in the investor presentation with the milestones is to get approval in Australia first with the TGA. Implement the business model of pricing ,marketing etc here in Australia ironing out lessons learned prior to implementing it on the Europe and then finally the USA and FDA approval. This approach of using Australia as the test market to getting the business strategy right before taking on the USA makes sense to me and was also explained is a strategy a lot of medical/drug companies adopt including those based in the USA.
Australia has a good advanced society with good healthcare system that makes it suitable as a test market of companies. This also comes with less cost of roll out. Companies have one chance to get it right in the big USA market , you want to be sure and see proof that you have the right business strategy.....
This is why I rate the calibre of this management they have done it before for some of the biggest medical companies going around, and they did it when those companies were starting out.
- Forums
- ASX - By Stock
- Ann: Change of Company Name-MNQ.AX
I also remember when I was at the meeting that the strategy...
-
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MNQ (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online